Skip to content
financeLOW2026-04-22 05:45 UTC

Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty

Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty
ORIGINAL SOURCE →via Investing.com
ADVERTISEMENT
⚡ STAY AHEAD

Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.

GET THE SUNDAY BRIEFING →

RELATED · finance